The latest price target for General Dynamics (NYSE:GD) was reported by JP Morgan on October 28, 2025. The analyst firm set a price target for $380.00 expecting GD to rise to within 12 months (a ...
About Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback